Edward Tobinick MD Blog

Comments: 0

Improvement in left-side neglect and pain minutes after treatment by Edward Tobinick, M.D., on August 30, 2021

Perispinal etanercept treatment by Dr. Tobinick. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, on August 30, 2021.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Thursday, September 9, 2021 at 3:58 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Post Stroke Pain, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Immediate stroke improvements after treatment by Edward Tobinick, M.D. in August 2021

Perispinal etanercept treatment by Dr. Tobinick. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, in August 2021.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Tuesday, August 17, 2021 at 9:28 am
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Post Stroke Pain, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Swedish stroke survivor regains ability to walk and becomes pain-free following treatment by Edward Tobinick, M.D.

Swedish stroke survivor regains ability to walk without assistance and becomes pain-free following perispinal etanercept treatment by Edward Tobinick, M.D. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, August 3, 2021.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Friday, August 6, 2021 at 4:11 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Post Stroke Pain, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Immediate improvement in hand & leg function, etc., more than 3 years after stroke following treatment by Edward Tobinick, M.D.

Improvements in hand function, walking, balance, speech, and sensation following perispinal etanercept treatment by Dr. Tobinick on July 9, 2021, more than 3 years after the stroke occurred. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Tuesday, August 3, 2021 at 3:48 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Immediate improvements 1 year post-stroke after treatment by Edward Tobinick, M.D.

Immediate improvements in walking and balance following perispinal etanercept treatment by Dr. Tobinick. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, on July 8, 2021.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Thursday, July 15, 2021 at 4:11 pm
Filed under Blog Posts, Brain Research, INR News, Uncategorized · Tagged with #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

About Dr. Tobinick

Edward Lewis Tobinick is an American physician who is the inventor of the perispinal etanercept treatment for chronic stroke pain whose efficacy has been established by a randomized, double-blind, placebo-controlled clinical trial published in January 2020.

Dr. Tobinick graduated Phi Beta Kappa and Magna Cum Laude with honors in biology from Brandeis University in Waltham, Massachusetts and received his M.D. from the University of California San Diego School of Medicine in La Jolla, California.

The published scientific articles documenting unprecedented neurological effects produced by the novel method of drug delivery invented by Dr. Tobinick have been cited by hundreds of scientists from academic centers around the world.

Dr. Tobinick's breakthrough stroke treatment has been used to treat patients from every continent in the world, including from the U.S., Canada, England, Scotland, Wales, Ireland, Mexico, Trinidad, Jamaica, Haiti, Bahamas, Guatemala, Belize, Brazil, Columbia, Bolivia, Uruguay, Ecuador, Chile, Peru, Germany, France, Spain, Italy, Portugal, Belgium, Netherlands, Switzerland, Bulgaria, Romania, Ukraine, Poland, Denmark, Sweden, Norway, Iceland, Gibraltar, Uzbekistan, Turkey, Israel, Saudi Arabia, UAE, Oman, Iraq, Egypt, Morocco, Nigeria, Ghana, Cameroon, South Africa, Mozambique, Kenya, Mauritius, India, Bangladesh, Thailand, Vietnam, China, Hong Kong, Japan, Indonesia, Malaysia, Philippines, Australia, New Zealand, Papua New Guinea, Fiji, and the Cook Islands.

In 2018 the Australian Minister of Health, Hon. Greg Hunt, designated substantial funds to study Dr. Tobinick's breakthrough stroke treatment in Australia.

Dr. Tobinick has been an invited ad hoc reviewer for the journals Brain Research, Clinical Drug Investigation, CNS Drugs, Current Alzheimer Research, Experimental Neurology, Future Neurology, Journal of Neurochemistry, Journal of Neuroimmunology, Neuroscience, and Pharmaceutical Medicine and a member of the Editorial Board of the Journal of Neuroinflammation.

More Info